FDA Inspection 1241786 — Novartis Pharma AG
The FDA completed an inspection of Novartis Pharma AG on Jun 4, 2024 in Basel. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI)
- End Date
- Jun 4, 2024
- Fiscal Year
- 2024
- Product Type
- Drugs
- Project Area
- Bioresearch Monitoring
- Location
- Basel (Switzerland)
Additional Details
Sponsor, Contract Research Organization